Clinical trials recruiting for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
3
Recruiting trials
0
US states with sites
1
Countries
33%
Accept healthy volunteers
Phase breakdown
Early Phase 1 2Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CT103A cells | 1 |
| Cyclophosphamide and fludarabine | 1 |
| UCAR T-cell | 1 |
Self-screener
Recruiting trials
- Biomarkers in Autoimmune Disease of Nervous System
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
Related conditions
Trials recruiting for Chronic Inflammatory Demyelinating Polyradiculoneuropathy often also study these conditions. Each links to its own recruiting-trial list.
Myasthenia Gravis 10Multiple sclerosis 445Autoimmune Encephalitis 6Neuromyelitis Optica Spectrum Disorder 5Idiopathic Inflammatory Myopathies 11Autoimmune Diseases of the Nervous System 4Autoimmune Diseases 29Neuromyelitis Optica Spectrum Disorders 5Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) 4Acute Disseminated Encephalomyelitis 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.